🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Assess the sensitivity, specificity, positive predictive value, and negativ...
Status
Recruiting
Location
The Third Affiliated Hospital of Guangzhou Medical University
Start Date
2024-01-01
Trial ID
NCT06420427
Treatments Being Tested
Conduct a prospective study to confirm the value of circulating tumor DNA a...
Status
Unknown
Location
Peking University People's Hospital
Start Date
2018-08-15
Trial ID
NCT03634826
The conception of molecular residual disease (MRD) extending from hematolog...
Status
Recruiting
Location
Guangdong Lung Cancer Institute & Guangdong Provincial People's Hospital
Start Date
2021-09-01
Trial ID
NCT04976296
Treatments Being Tested
This prospective observational study (PKU-ESCC-Monitor) aims to characteriz...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2025-09-01
Trial ID
NCT07152535
The goal of this clinical trial is to explore the predictive effect of post...
Status
Recruiting
Location
Fudan University Shanghai Cancer Center
Start Date
2023-10-01
Trial ID
NCT06903325
Treatments Being Tested
This study aims to evaluate the clinical value of circulating tumor DNA (ct...
Status
Recruiting
Location
Fudan University Shanghai Cancer Center
Start Date
2026-01-01
Trial ID
NCT07517107
Treatments Being Tested
Multi-center observational clinical study to evaluate the application value...
Status
Recruiting
Location
Fudan University Shanghai Cancer Center
Start Date
2025-10-10
Trial ID
NCT07283575
Treatments Being Tested
The goal of this adaptive, interventional study is to assess the efficacy a...
Status
Recruiting
Location
Shanghai Chest Hospital, School of Medicine, Shanghai Jiao Tong University
Start Date
2025-09-23
Trial ID
NCT07058519
Treatments Being Tested
Leptomeningeal metastases (LM) are a relatively rare site of metastasis in ...
Status
Recruiting
Location
Wuhan Union Hospital
Start Date
2025-04-15
Trial ID
NCT07092202
Treatments Being Tested